FAILURE OF CCK RECEPTOR LIGANDS TO MODIFY ANXIETY-RELATED BEHAVIORAL SUPPRESSION IN AN OPERANT CONFLICT PARADIGM IN RATS

Citation
D. Charrier et al., FAILURE OF CCK RECEPTOR LIGANDS TO MODIFY ANXIETY-RELATED BEHAVIORAL SUPPRESSION IN AN OPERANT CONFLICT PARADIGM IN RATS, Psychopharmacology, 121(1), 1995, pp. 127-134
Citations number
44
Categorie Soggetti
Neurosciences,Psychiatry,"Pharmacology & Pharmacy",Neurosciences,Psychiatry,"Pharmacology & Pharmacy
Journal title
Volume
121
Issue
1
Year of publication
1995
Pages
127 - 134
Database
ISI
SICI code
Abstract
The effects of cholecystokinin (CCK) receptor ligands were studied in the rat safety signal withdrawal conflict procedure, an operant paradi gm sensitive to both anxiolytic and anxiogenic compounds. In this proc edure, behavioural suppression of lever pressing for food was induced by the withdrawal of a conditioned signal for safety without the usual presentation of a conditioned signal for danger. The compounds tested were selective CCK-B antagonists [CI-988 (0.01-1 mg/kg SC), L-365,260 (0.0042 mg/kg IF) and LY 262,691 (0.001-1 mg/kg SC)], CCK-B agonists [CCK-4 (0.01-1 mg/kg SC) and BC 264 (0.004-2 mg/kg IP)] and CCK-A anta gonists [devazepide (0.001-1 mg/kg SC) and lorglumide (0.01-1 mg/kg SC )]. None of these drugs induced the expected behavioural effects, i.e. an anxiolytic-like release of the behavioural suppression with CCK-B and, possibly, CCK-A antagonists and/or a further reduction of lever p ressing with CCK-B agonists, indicative of an anxiogenic-like potentia l. In contrast, the established anxiolytic lorazepam (0.06-0.25 mg/kg IP), as well as diazepam (2 mg/kg IP) and buspirone (0.25mg/kg SC) use d as positive control drugs, released the suppression of pressing for food during the period associated with the safety signal withdrawal, w hereas picrotoxin(1 mg/kg IF), used as an anxiogenic control, further reduced responding during this conflict period. The present results co ntrast with a series of published data suggesting the involvement of C CK processes in anxiety-related behaviour in rodent models such as the elevated plus-maze or the light:dark two compartment test, and in pan ic disorders in humans. They indicate that the behavioural effects of one category of drugs might vary considerably, depending on the experi mental situation. Furthermore, they allow the conclusion that anticipa tory anxiety generated by withdrawal of conditioned signals for safety does not involve CCK-related processes.